Biotech Co. Celldex Completes $90M Curagen Buy

By Elaine Meyer · October 2, 2009, 5:24 PM EDT

Biotechnology company Celldex Therapeutics Inc. has completed its purchase of fellow cancer drug maker Curagen Corp. for more than $90 million, the companies have announced....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Elaine

November 05, 2010
Astellas Targets Glenmark Over Eczema Drug
November 01, 2010
Fed. Circ. Upholds Injunction On Generic Pulmicort
October 27, 2010
Customs Improperly Classified Surgical Lamps: CIT
October 22, 2010
Sidley Advises GE Healthcare In $580M Clarient Deal
October 18, 2010
FDA Panel OKs Use Of Anemia Drugs, Despite Study
October 13, 2010
Howmedica Polymers Patents Invalid: Fed Circ.
October 07, 2010
Consumers Target J&J Unit Over Listerine Marketing
October 07, 2010
Novo Can't Shake Bid To Invalidate Prandin Patent
September 27, 2010
Novo Nordisk To Challenge Russian Competition Fine
September 27, 2010
UPS Hit With ERISA Suit Over Health Benefits